$TLRY
Tilray Brands, Inc. Stock $tlry

$tlry Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000143774923020727 Filed on July 26, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue	$176.9M	$184.2M	$627.1M
YoY Change	15.49%	20.13%	-0.2%
Cost Of Revenue	$132.8M	$117.0M	$480.2M
YoY Change	26.92%	-26.89%	-6.14%
Gross Profit	$44.20M	$67.16M	$147.0M
YoY Change	-9.09%	-1097.52%	25.8%
Gross Profit Margin	24.98%	36.46%	23.43%
Selling, General & Admin	$47.38M	-$116.7M	$231.0M
YoY Change	-5.59%	-286.78%	16.82%
% of Gross Profit	107.19%	-173.8%	157.17%
Research & Development	$79.00K	$180.0K	$682.0K
YoY Change	-52.41%	233.33%	-55.07%
% of Gross Profit	0.18%	0.27%	0.46%
Depreciation & Amortization	$30.79M	$28.99M	$130.1M
YoY Change	-9.62%	-28.88%	-15.81%
% of Gross Profit	69.67%	43.17%	88.56%
Operating Expenses	$78.56M	-$94.64M	$326.0M
YoY Change	12.56%	-242.08%	-55.17%
Operating Profit	-$34.36M	$161.8M	-$179.1M
YoY Change	62.25%	-320.61%	-70.67%
Interest Expense	-$9.835M	-$267.6M	-$318.9M
YoY Change	122.86%	7466.04%	-903.57%
% of Operating Profit		-165.39%
Other Income/Expense, Net	-$4.402M	-$426.0K	-$7.971M
YoY Change	-86.66%	-104.55%	-104.03%
Pretax Income	-$48.60M	-$111.7M	-$1.450B
YoY Change	-17.04%	-75.8%	229.08%
Income Tax	$7.264M	$8.132M	-$7.181M
% Of Pretax Income
Net Earnings	-$71.53M	-$138.7M	-$1.453B
YoY Change	-2.66%	-70.99%	204.67%
Net Earnings / Revenue	-40.42%	-75.31%	-231.64%
Basic Earnings Per Share	-$0.10		-$2.35
Diluted Earnings Per Share	-$0.10	-$0.20	-$2.35
COMMON SHARES
Basic Shares Outstanding	703.3M	618.0M	618.0M
Diluted Shares Outstanding	691.2M		618.0M

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$464.9M	$448.5M	$448.5M
YoY Change	-5.25%	7.84%	7.84%
Cash & Equivalents	$177.5M	$206.6M	$206.6M
Short-Term Investments	$287.3M	$241.9M	$241.9M
Other Short-Term Assets	$50.20M	$37.72M	$37.72M
YoY Change	-35.01%	-19.37%	-19.37%
Inventory	$232.1M	$200.6M	$200.6M
Prepaid Expenses
Receivables	$82.08M	$86.23M	$86.23M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$829.3M	$773.0M	$773.0M
YoY Change	-8.96%	-3.79%	-3.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$494.6M	$435.6M	$435.6M
YoY Change	-10.66%	-25.85%	-27.46%
Goodwill	$2.010B	$2.009B
YoY Change	-23.23%	-23.95%
Intangibles	$967.6M	$973.8M
YoY Change	-20.07%	-23.8%
Long-Term Investments	$4.638M	$12.37M	$12.37M
YoY Change	-2.64%	-17.54%	-17.54%
Other Assets	$8.647M	$222.0K	$222.0K
YoY Change	81.89%	-29.3%	-29.3%
Total Long-Term Assets	$3.573B	$3.534B	$3.534B
YoY Change	-23.68%	-23.93%	-23.93%
TOTAL ASSETS
Total Short-Term Assets	$829.3M	$773.0M	$773.0M
Total Long-Term Assets	$3.573B	$3.534B	$3.534B
Total Assets	$4.402B	$4.307B	$4.307B
YoY Change	-21.28%	-20.96%	-20.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$78.97M	$70.82M	$70.82M
YoY Change	4.13%	3.23%	3.23%
Accrued Expenses	$129.5M	$107.4M	$107.4M
YoY Change	106.19%	86.71%	20.11%
Deferred Revenue
YoY Change
Short-Term Debt	$14.59M	$23.38M	$23.38M
YoY Change	-20.17%	29.01%	29.01%
Long-Term Debt Due	$265.1M	$198.5M	$198.5M
YoY Change	313.59%	192.61%	192.61%
Total Short-Term Liabilities	$537.3M	$433.0M	$433.0M
YoY Change	96.62%	54.45%	54.45%
LONG-TERM LIABILITIES
Long-Term Debt	$273.3M	$368.8M	$368.8M
YoY Change	-51.07%	212.88%	-29.05%
Other Long-Term Liabilities	$74.00K	$8.151M	$8.151M
YoY Change	-58.66%	4167.54%	-29.24%
Total Long-Term Liabilities	$74.00K	$377.0M	$377.0M
YoY Change	-58.66%	219.28%	-29.05%
TOTAL LIABILITIES
Total Short-Term Liabilities	$537.3M	$433.0M	$433.0M
Total Long-Term Liabilities	$74.00K	$377.0M	$377.0M
Total Liabilities	$1.001B	$991.6M	$991.6M
YoY Change	-2.78%	-1.66%	-5.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.487B	-$2.416B
YoY Change	139.98%	150.87%
Common Stock	$5.910B	$5.778B
YoY Change	4.76%	7.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.379B	$3.316B	$3.316B
YoY Change
Total Liabilities & Shareholders Equity	$4.402B	$4.307B	$4.307B
YoY Change	-21.28%	-20.96%	-20.96%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	-$71.53M	-$138.7M	-$1.453B
YoY Change	-2.66%	-70.99%	204.67%
Depreciation, Depletion And Amortization	$30.79M	$28.99M	$130.1M
YoY Change	-9.62%	-28.88%	-15.81%
Cash From Operating Activities	-$15.84M	$43.60M	$7.906M
YoY Change	-65.76%	-312.42%	-104.46%
INVESTING ACTIVITIES
Capital Expenditures	$4.150M	$12.41M	$20.80M
YoY Change	-238.33%	-321.77%	-161.06%
Acquisitions	-$22.96M		$26.72M
YoY Change			-8295.71%
Other Investing Activities	-$22.14M	$4.822M	-$264.3M
YoY Change	-1613.33%	610.16%	-2209.26%
Cash From Investing Activities	-$26.29M	-$7.584M	-$285.1M
YoY Change	1610.47%	54.3%	1224.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$128.4M
YoY Change			-51.09%
Debt Paid & Issued, Net	$6.369M
YoY Change	22.58%
Cash From Financing Activities	$14.02M	6.236M	70.16M
YoY Change	-88.66%	-96.15%	-45.27%
NET CHANGE
Cash From Operating Activities	-$15.84M	43.60M	7.906M
Cash From Investing Activities	-$26.29M	-7.584M	-285.1M
Cash From Financing Activities	$14.02M	6.236M	70.16M
Net Change In Cash	-$27.50M	42.25M	-207.0M
YoY Change	-136.8%	-69.02%	185.36%
FREE CASH FLOW
Cash From Operating Activities	-$15.84M	$43.60M	$7.906M
Capital Expenditures	$4.150M	$12.41M	$20.80M
Free Cash Flow	-$19.99M	$31.19M	-$12.89M
YoY Change	-53.8%	-308.92%	-91.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	990000000
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	990000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	656655455
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	656655455
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	532674887
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	532674887
CY2023	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
CY2022	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	656655455
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	532674887
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-05-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38594
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-4310622
CY2023Q2	us-gaap	Assets Assets	4307259000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	222000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	314000	usd
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	265 Talbot Street West
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Leamington
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	ON
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	N8H 5L4
CY2023	dei	City Area Code CityAreaCode	844
CY2023	dei	Local Phone Number LocalPhoneNumber	845-7291
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2023	dei	Trading Symbol TradingSymbol	TLRY
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Public Float EntityPublicFloat	2400000000	usd
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	703257224
CY2023	dei	Auditor Firm AuditorFirmId	271
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	206632000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	415909000	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	241897000	usd
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	86227000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	95279000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	200551000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	245529000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	37722000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	46786000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	773029000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	803503000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	429667000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	587499000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5941000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12996000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	973785000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1277875000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	2008843000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	2641305000	usd
CY2023Q2	us-gaap	Equity Method Investments EquityMethodInvestments	4576000	usd
CY2022Q2	us-gaap	Equity Method Investments EquityMethodInvestments	4952000	usd
CY2023Q2	us-gaap	Other Long Term Investments OtherLongTermInvestments	7795000	usd
CY2022Q2	us-gaap	Other Long Term Investments OtherLongTermInvestments	10050000	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	103401000	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	111200000	usd
CY2022Q2	us-gaap	Assets Assets	5449694000	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	23381000	usd
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	18123000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	190682000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	157431000	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	16218000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	16007000	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1817000	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	14255000	usd
CY2023Q2	tlry	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	2423000	usd
CY2022Q2	tlry	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	6703000	usd
CY2023Q2	us-gaap	Secured Debt Current SecuredDebtCurrent	24080000	usd
CY2022Q2	us-gaap	Secured Debt Current SecuredDebtCurrent	67823000	usd
CY2023Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	174378000	usd
CY2022Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	432979000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	280342000	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	10889000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2023Q2	tlry	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	7936000	usd
CY2022Q2	tlry	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	11329000	usd
CY2023Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	136889000	usd
CY2022Q2	us-gaap	Secured Long Term Debt SecuredLongTermDebt	117879000	usd
CY2023Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	221044000	usd
CY2022Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	401949000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	167364000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	196638000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	215000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	191000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	977316000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	1008328000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	66000	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	53000	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5777743000	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5382367000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-46610000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20764000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2415507000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-962851000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3315692000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4398805000	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	14251000	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	42561000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3329943000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4441366000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4307259000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5449694000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	627124000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	628372000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	513085000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	480164000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	511555000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	389903000	usd
CY2023	us-gaap	Gross Profit GrossProfit	146960000	usd
CY2022	us-gaap	Gross Profit GrossProfit	116817000	usd
CY2021	us-gaap	Gross Profit GrossProfit	123182000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	165159000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	162801000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	111575000	usd
CY2023	us-gaap	Selling Expense SellingExpense	34840000	usd
CY2022	us-gaap	Selling Expense SellingExpense	34926000	usd
CY2021	us-gaap	Selling Expense SellingExpense	26576000	usd
CY2023	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	93489000	usd
CY2022	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	115191000	usd
CY2021	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	35221000	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	30937000	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	30934000	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	17539000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	682000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1518000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	830000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	855000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-44650000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	934000000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	378241000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	tlry	Otherthantemporary Fair Value Loss Convertible Notes Receivable OtherthantemporaryFairValueLossConvertibleNotesReceivable	246330000	usd
CY2022	tlry	Otherthantemporary Fair Value Loss Convertible Notes Receivable OtherthantemporaryFairValueLossConvertibleNotesReceivable	0	usd
CY2021	tlry	Otherthantemporary Fair Value Loss Convertible Notes Receivable OtherthantemporaryFairValueLossConvertibleNotesReceivable	0	usd
CY2023	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	-505000	usd
CY2022	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	16518000	usd
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	3251000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	9245000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	795000	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2023	tlry	Transaction Costs TransactionCosts	1613000	usd
CY2022	tlry	Transaction Costs TransactionCosts	30944000	usd
CY2021	tlry	Transaction Costs TransactionCosts	60361000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1516645000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	727218000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	255353000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1369685000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-610401000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-132171000	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-13587000	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-27944000	usd
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-27977000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-66909000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	197671000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-184838000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1450181000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-440674000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-344986000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7181000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6542000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8972000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-1443000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-434132000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-336014000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1452656000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-476801000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-367421000	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	9656000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	42669000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	31407000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-83533000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-125306000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	156649000	usd
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	75177000	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-71428000	usd
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3824000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-8356000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-196734000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	152825000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1451356000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-630866000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-183189000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1478502000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-650233000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-214596000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	27146000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	19367000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	31407000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	617982589
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	481219130
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	269549852
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	617982589
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	481219130
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	269549852
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.35
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.99
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.36
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.35
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.99
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.36
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1274931000	usd
CY2021	tlry	Stock Issued During Period Value Legal Settlement StockIssuedDuringPeriodValueLegalSettlement	10454000	usd
CY2021	tlry	Stock Issued During Period Value Equity Financing StockIssuedDuringPeriodValueEquityFinancing	103537000	usd
CY2021	tlry	Stock Issued During Period Value Contract Settlement StockIssuedDuringPeriodValueContractSettlement	-18895000	usd
CY2021	tlry	Stock Issued During Period Value Arrangement StockIssuedDuringPeriodValueArrangement	3204906000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	144000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	19391000	usd
CY2021	tlry	Adjustments To Additional Paid In Capital Settlement Of Convertible Notes Receivable AdjustmentsToAdditionalPaidInCapitalSettlementOfConvertibleNotesReceivable	0	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	11855000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-183189000	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4465313000	usd
CY2022	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	52995000	usd
CY2022	tlry	Stock Issued During Period Value Equity Financing StockIssuedDuringPeriodValueEquityFinancing	262509000	usd
CY2022	tlry	Stock Issued During Period Value Settlement Of Financing Liability StockIssuedDuringPeriodValueSettlementOfFinancingLiability	-7484000	usd
CY2022	tlry	Stock Issued During Period Value Legal Settlement StockIssuedDuringPeriodValueLegalSettlement	22170000	usd
CY2022	tlry	Stock Issued During Period Value Purchase Of Capital And Intangible Assets StockIssuedDuringPeriodValuePurchaseOfCapitalAndIntangibleAssets	12146000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5403000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	8686000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35994000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-630866000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4441366000	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	6422000	usd
CY2023	tlry	Stock Issued During Period Value Equity Financing StockIssuedDuringPeriodValueEquityFinancing	129593000	usd
CY2023	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	107272000	usd
CY2023	tlry	Stock Issued During Period Value Settlement Of Financing Liability StockIssuedDuringPeriodValueSettlementOfFinancingLiability	12467000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2023	tlry	Stock Issued During Period Value Convertible Notes Share Lending Agreement StockIssuedDuringPeriodValueConvertibleNotesShareLendingAgreement	26161000	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1189000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39595000	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	7858000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-1451356000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3329943000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-1443000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-434132000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-336014000	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-31953000	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-27538000	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-24873000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-17768000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-18001000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-49342000	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	130149000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	154592000	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	67832000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	48000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	682000	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	55000000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	67000000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	19919000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	934001000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	378240000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	tlry	Otherthantemporary Fair Value Loss Convertible Notes Receivable OtherthantemporaryFairValueLossConvertibleNotesReceivable	246330000	usd
CY2022	tlry	Otherthantemporary Fair Value Loss Convertible Notes Receivable OtherthantemporaryFairValueLossConvertibleNotesReceivable	0	usd
CY2021	tlry	Otherthantemporary Fair Value Loss Convertible Notes Receivable OtherthantemporaryFairValueLossConvertibleNotesReceivable	0	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-11406000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	9647000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1502000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	39595000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	35994000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	17351000	usd
CY2023	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-2190000	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-4914000	usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-1624000	usd
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-31213000	usd
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	227583000	usd
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-169537000	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	855000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-44650000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	59917000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4168000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5842000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	23512000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3122000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4472000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6772000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12934000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	45749000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	55205000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	20044000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-44652000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	14635000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7906000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-177262000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44717000	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	20800000	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	34064000	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	38874000	usd
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	4304000	usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	12205000	usd
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	6608000	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	-0	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	-0	usd
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	2419000	usd
CY2023	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	0	usd
CY2022	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	0	usd
CY2021	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	5752000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	241897000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-0	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-0	usd
CY2023	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
CY2022	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	8430000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	26718000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-326000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-66608000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-285111000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21533000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	46105000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	129593000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	262509000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	102550000	usd
CY2023	tlry	Proceeds From Payment For Warrants And Options Exercised ProceedsFromPaymentForWarrantsAndOptionsExercised	0	usd
CY2022	tlry	Proceeds From Payment For Warrants And Options Exercised ProceedsFromPaymentForWarrantsAndOptionsExercised	5403000	usd
CY2021	tlry	Proceeds From Payment For Warrants And Options Exercised ProceedsFromPaymentForWarrantsAndOptionsExercised	144000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1189000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8686000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	-0	usd
CY2023	tlry	Proceeds From Convertible Debt Issuance ProceedsFromConvertibleDebtIssuance	145052000	usd
CY2022	tlry	Proceeds From Convertible Debt Issuance ProceedsFromConvertibleDebtIssuance	0	usd
CY2021	tlry	Proceeds From Convertible Debt Issuance ProceedsFromConvertibleDebtIssuance	0	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	187394000	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	88026000	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-0	usd
CY2023	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1288000	usd
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	102798000	usd
CY2023	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	21336000	usd
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	40254000	usd
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	64559000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1114000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4672000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1058000	usd
CY2023	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	5258000	usd
CY2022	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	9406000	usd
CY2021	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	8328000	usd
CY2023	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	-0	usd
CY2022	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	7484000	usd
CY2021	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	23895000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	70158000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	128196000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	124308000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2230000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1958000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2124000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-209277000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-72557000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	127820000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	415909000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	488466000	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	360646000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	206632000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	415909000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	488466000	usd
CY2023	us-gaap	Basis Of Accounting BasisOfAccounting	<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"><tbody><tr><td style="vertical-align:top;width:2.8%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><em style="font: inherit;">2.</em></b></p> </td><td style="vertical-align:top;width:auto;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Basis of preparation</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The policies applied in these consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”).</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Based on the determination that Aphria was the accounting acquirer in the Arrangement, Aphria’s historical financial statements became the historical financial statements of the Company. The results of Tilray's operations and cash flows are included in the Company’s consolidated statement of loss and comprehensive loss and cash flows for periods beginning after <em style="font: inherit;"> April 30, 2021. </em>In conjunction with the reverse acquisition, the Company elected to adopt Aphria’s fiscal year end of <em style="font: inherit;"> June 1 </em>to <em style="font: inherit;"> May 31. </em>Accordingly, comparisons between the Company's results for the years ended <em style="font: inherit;"> May 31, 2023</em> and <em style="font: inherit;"> May 31, 2022 </em>with prior periods <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be meaningful, as the reported results do <em style="font: inherit;">not</em> include the operations of legacy-Tilray and its subsidiaries on and prior to <em style="font: inherit;"> April 30, 2021.</em></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">These consolidated financial statements have been prepared on the going concern basis which assumes that the Company will continue in operation for the foreseeable future and, accordingly, will be able to realize its assets and discharge its liabilities in the normal course of operations as they come due, under the historical cost convention except for certain financial instruments that are measured at fair value, as detailed in the Company’s accounting policies. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"><i>Foreign currency</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">These consolidated financial statements are presented in U.S. dollars (“USD”), which is the Company’s reporting currency; however, the functional currency of the entities in these financial statements are their respective local currencies, including Canadian dollar, USD, Euro, Australian dollar, and Great Britain pound.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Foreign currency transactions are remeasured to the respective functional currencies of the Company’s entities at the exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies are remeasured to the functional currency at the foreign exchange rate applicable at the statement of financial position date. Non-monetary items carried at historical cost denominated in foreign currencies are remeasured to the functional currency at the date of the transactions. Non-monetary items carried at fair value denominated in foreign currencies are remeasured to the functional currency at the date when the fair value was determined. Realized and unrealized exchange gains and losses are recognized through profit and loss.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On consolidation, the assets and liabilities of foreign operations reported in their functional currencies are translated into USD, the Group’s presentation currency, at period-end exchange rates. Income and expenses, and cash flows of foreign operations are translated into USD using average exchange rates. Exchange differences resulting from translating foreign operations are recognized in other comprehensive income (loss) and accumulated in equity.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"><i>Basis of consolidation </i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The consolidated financial statements of the Company, include the accounts of the company, its wholly-owned subsidiaries and majority owned subsidiaries see Note <em style="font: inherit;">21</em> (Non-controlling interests). All significant intercompany transactions are eliminated.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"><i>Equity method investments</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In accordance with ASC <em style="font: inherit;">323,</em> <i>Investments </i>–<i> Equity Method and Joint Ventures, </i>investments in entities over which the Company does <em style="font: inherit;">not</em> have a controlling financial interest but has significant influence are accounted for using the equity method, with the Company’s share of earnings or losses reported in earnings or losses from equity method investments on the statements of net loss and comprehensive loss. Equity method investments are recognized initially at cost, which includes transaction costs. After initial recognition, the consolidated financial statements include the Company’s share of undistributed earnings or losses, and impairment, if any, until the date on which significant influence ceases.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">If the Company’s share of losses in an equity investment equals or exceeds its interest in the entity, including any net advances, the group does <em style="font: inherit;">not</em> recognize further losses, unless it has guaranteed obligations of the investee or is otherwise committed to provide further financial support for the investee.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Unrealized gains on transactions between the Company and its equity-method investees are eliminated only to the extent of the Company’s interest in these entities. Unrealized losses are also eliminated, except to the extent that the underlying asset is impaired. </p>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"><i>Critical accounting estimates and judgments</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The preparation of the Company’s financial statements requires management to make judgments, estimates and assumptions that affect the application of policies and reported amounts of assets, liabilities, revenues and expenses. These estimates and judgements are subject to change based on experience and new information which could result in outcomes that require a material adjustment to the carrying amounts of assets or liabilities affecting future periods. Actual results <em style="font: inherit;"> may </em>differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized prospectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Financial statement areas that require significant judgement and estimates are as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Long-term investments and convertible notes receivable </i>–<i> </i>The determination of fair value of the Company’s long-term investments and convertible notes receivable at other than initial cost is subject to certain limitations. Financial information for private companies in which the Company has investments <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be available and, even if available, that information <em style="font: inherit;"> may </em>be limited and/or unreliable.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Use of the valuation approach described below <em style="font: inherit;"> may </em>involve uncertainties and determinations based on the Company’s judgment and any value estimated from these techniques <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be realized or realizable.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Company-specific information is considered when determining whether the fair value of a long-term investment or convertible notes receivable should be adjusted upward or downward at the end of each reporting period. In addition to company-specific information, the Company will consider trends in general market conditions and the share performance of comparable publicly traded companies when valuing long-term investments and convertible notes receivable.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The fair value of long-term investments and convertible notes receivable <em style="font: inherit;"> may </em>need to be adjusted if:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">•</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">There has been a significant subsequent equity financing provided by outside investors at a valuation different than the current value of the investee company, in which case the fair value of the investment is set to the value at which that financing took place;</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">•</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">There have been significant corporate, political, or operating events affecting the investee company that, in management’s opinion, have a material impact on the investee company’s prospects and therefore its fair value. In these circumstances, the adjustment to the fair value of the investment will be based on management’s judgment and any value estimated <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be realized or realizable;</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">•</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">The investee company is placed into receivership or bankruptcy;</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">•</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Based on financial information received from the investee company, it is apparent to the Company that the investee company is unlikely to be able to continue as a going concern;</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> </td><td style="width: 18pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">•</p> </td><td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Important positive or negative management changes by the investee company that the Company’s management believes will have a positive or negative impact on the investee company’s ability to achieve its objectives and build value for shareholders.</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Adjustment to the fair value of a long-term investment and convertible notes receivable will be based upon management’s judgment and any value estimated <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be realized or realizable. The resulting values for non-publicly traded investments <em style="font: inherit;"> may </em>differ from values that would be realized if a ready market existed.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Estimated useful lives, impairment considerations and amortization of capital and intangible assets </i>–<i> </i>Amortization of capital and intangible assets is dependent upon estimates of useful lives based on management’s judgment. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Goodwill and indefinite-lived intangible asset impairment testing require management to make estimates in the impairment testing model. On at least an annual basis, the Company tests whether goodwill and indefinite-lived intangible assets are impaired. Impairment of definite long-lived assets is influenced by judgment in defining a reporting unit and determining the indicators of impairment, and estimates used to measure impairment losses</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The reporting unit’s fair value is determined using discounted future cash flow models, which incorporate assumptions regarding future events, specifically future cash flows, growth rates and discount rates.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Stock-based compensation </i>–<i> </i>The fair value of stock-based compensation expenses are estimated using the Black-Scholes option pricing model and rely on a number of assumptions including the fair value of common shares on the grant date, risk-free rate, volatility rate, annual dividend yield, the expected term, and the estimated rate of forfeiture of options granted. Volatility is estimated by using the historical volatility of the Company.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Business combinations </i>–<i> </i>Judgement is used in determining a) whether an acquisition is a business combination or an asset acquisition. We use judgement in applying the acquisition method of accounting for business combinations and estimates to value identifiable assets and liabilities at the acquisition date. Estimates are used to determine cash flow projections, including the period of future benefit, and future growth and discount rates, among other factors. The values allocated to the acquired assets and liabilities assumed affect the amount of goodwill recorded on acquisition. Fair value of assets acquired and liabilities assumed is typically estimated using an income approach, which is based on the present value of future discounted cash flows. Significant estimates in the discounted cash flow model include the discount rate, rate of future revenue growth and profitability of the acquired business and working capital effects. The discount rate considers the relevant risk associated with the business-specific characteristics and the uncertainty related to the ability to achieve projected cash flows. These estimates and the resulting valuations require significant judgment. Management engages <em style="font: inherit;">third</em> party experts to assist in the valuation of material acquisitions.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Convertible debentures </i>–<i> </i>The fair value of Convertible Debentures where the Company had elected the fair value option are determined using the Black-Scholes option pricing model. Assumptions and estimates are made in determining an appropriate conversion price, volatility, dividend yield, and the fair value of common stock. There is judgement in assessing what portion of the gain or loss, if any, relates to the change in the instrument-specific credit risk.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Warrant liability </i>–<i> </i>The fair value of the warrant liability is measured using a Black Scholes pricing model. Assumptions and estimates are made in determining an appropriate risk-free interest rate, volatility, term, dividend yield, discount due to exercise restrictions, and the fair value of common stock. Any significant adjustments to the unobservable inputs would have a direct impact on the fair value of the warrant liability.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q2	us-gaap	Inventory Net InventoryNet	200551000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	245529000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	576485000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	754740000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	146818000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	167241000	usd
CY2023Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	429667000	usd
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	587499000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5941000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12996000	usd
CY2023Q2	tlry	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	10359000	usd
CY2022Q2	tlry	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	18032000	usd
CY2023	us-gaap	Lease Cost LeaseCost	3140000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	662000	usd
CY2022	us-gaap	Lease Cost LeaseCost	3499000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	553000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4106000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3295000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3486000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3412000	usd
CY2023Q2	tlry	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	4012000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	18311000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	7952000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	10359000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1576717000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1642843000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	187088000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	154124000	usd
CY2023Q2	tlry	Intangible Assets Net Excluding Goodwill Accumulated Impairment IntangibleAssetsNetExcludingGoodwillAccumulatedImpairment	415844000	usd
CY2022Q2	tlry	Intangible Assets Net Excluding Goodwill Accumulated Impairment IntangibleAssetsNetExcludingGoodwillAccumulatedImpairment	210844000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	973785000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1277875000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	74169000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	72502000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	72502000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	72502000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	72502000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	428515000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	792692000	usd
CY2023Q2	tlry	Goodwill Accumulated Foreign Currency Translation Gain Loss GoodwillAccumulatedForeignCurrencyTranslationGainLoss	-7875000	usd
CY2022Q2	tlry	Goodwill Accumulated Foreign Currency Translation Gain Loss GoodwillAccumulatedForeignCurrencyTranslationGainLoss	-39640000	usd
CY2023Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	842431000	usd
CY2022Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	223931000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	2008843000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	2641305000	usd
CY2023Q2	us-gaap	Notes Receivable Net NotesReceivableNet	103401000	usd
CY2022Q2	us-gaap	Notes Receivable Net NotesReceivableNet	111200000	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	0	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	0	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	103401000	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	111200000	usd
CY2023Q2	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	2144000	usd
CY2022Q2	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	4347000	usd
CY2023Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	5651000	usd
CY2022Q2	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	5703000	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	7795000	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	10050000	usd
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	8430000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-2366000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-6731000	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1567000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-506984000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-233697000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-7814000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1450181000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-440674000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-344986000	usd
CY2022	tlry	Effective Income Tax Rate Reconciliation Nondeductible Taxable Losses EffectiveIncomeTaxRateReconciliationNondeductibleTaxableLosses	748000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	226000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	262000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	26454000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24009000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	15924000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4055000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	520000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1517000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-33635000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-30551000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-24896000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7181000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6542000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8972000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1450181000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-440674000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-344986000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-304538000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-92542000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-72408000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-25857000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	81316000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-19016000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	13434000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	14941000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	1011000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3982000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	6404000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-1347000	usd
CY2023	tlry	Effective Income Tax Rate Reconciliation Nondeductible Taxable Losses EffectiveIncomeTaxRateReconciliationNondeductibleTaxableLosses	23150000	usd
CY2021	tlry	Effective Income Tax Rate Reconciliation Nondeductible Taxable Losses EffectiveIncomeTaxRateReconciliationNondeductibleTaxableLosses	45230000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-816000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	0	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	135000	usd
CY2023	tlry	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiability	-2612000	usd
CY2022	tlry	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiability	-13359000	usd
CY2021	tlry	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiability	-259000	usd
CY2023	tlry	Effective Income Tax Rate Reconciliation Stock Based And Other Compensation EffectiveIncomeTaxRateReconciliationStockBasedAndOtherCompensation	0	usd
CY2022	tlry	Effective Income Tax Rate Reconciliation Stock Based And Other Compensation EffectiveIncomeTaxRateReconciliationStockBasedAndOtherCompensation	994000	usd
CY2021	tlry	Effective Income Tax Rate Reconciliation Stock Based And Other Compensation EffectiveIncomeTaxRateReconciliationStockBasedAndOtherCompensation	2902000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	285698000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	17255000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	46007000	usd
CY2023	tlry	Effective Income Tax Rate Reconciliation Nondeductible Dividend EffectiveIncomeTaxRateReconciliationNondeductibleDividend	0	usd
CY2022	tlry	Effective Income Tax Rate Reconciliation Nondeductible Dividend EffectiveIncomeTaxRateReconciliationNondeductibleDividend	0	usd
CY2021	tlry	Effective Income Tax Rate Reconciliation Nondeductible Dividend EffectiveIncomeTaxRateReconciliationNondeductibleDividend	-755000	usd
CY2023	tlry	Effective Income Tax Rate Reconciliation Impact On Convertible Debenture And Other Differences EffectiveIncomeTaxRateReconciliationImpactOnConvertibleDebentureAndOtherDifferences	-378000	usd
CY2022	tlry	Effective Income Tax Rate Reconciliation Impact On Convertible Debenture And Other Differences EffectiveIncomeTaxRateReconciliationImpactOnConvertibleDebentureAndOtherDifferences	22299000	usd
CY2021	tlry	Effective Income Tax Rate Reconciliation Impact On Convertible Debenture And Other Differences EffectiveIncomeTaxRateReconciliationImpactOnConvertibleDebentureAndOtherDifferences	-0	usd
CY2023	tlry	Effective Income Tax Rate Reconciliation Effect Of Transaction EffectiveIncomeTaxRateReconciliationEffectOfTransaction	-0	usd
CY2022	tlry	Effective Income Tax Rate Reconciliation Effect Of Transaction EffectiveIncomeTaxRateReconciliationEffectOfTransaction	-0	usd
CY2021	tlry	Effective Income Tax Rate Reconciliation Effect Of Transaction EffectiveIncomeTaxRateReconciliationEffectOfTransaction	10472000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7181000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6542000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8972000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	85259000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	77868000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	34355000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	38087000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	244227000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	150543000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	46400000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	20592000	usd
CY2023Q2	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	2812000	usd
CY2022Q2	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	7165000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	66718000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	19055000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	22054000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	21590000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	50074000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	26976000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	715797000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	509775000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	625368000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	354071000	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	90429000	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	155704000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	18129000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	38387000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	225460000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	305577000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	14204000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	8378000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	257793000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	352342000	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	167364000	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	196638000	usd
CY2017Q4	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	70819000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	68604000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	82240000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	57497000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18772000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17736000	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	14934000	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	6150000	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	3869000	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	6772000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	48000	usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	672000	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	190682000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	157431000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	395422000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	401949000	usd
CY2023Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	174378000	usd
CY2022Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2023Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	221044000	usd
CY2022Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	401949000	usd
CY2022	tlry	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	5994651
CY2023Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	6209000
CY2022Q2	tlry	Class Of Warrant Or Right Original Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightOriginalExercisePriceOfWarrantsOrRights	5.95
CY2023Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.66
CY2023Q2	tlry	Percentage Of Daily Cash Penalty PercentageOfDailyCashPenalty	0.01	pure
CY2023Q2	tlry	Preferred Stock And Common Stock Shares Authorized PreferredStockAndCommonStockSharesAuthorized	990000000
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	656655455
CY2022Q2	tlry	Preferred Stock And Common Stock Shares Authorized PreferredStockAndCommonStockSharesAuthorized	743333333
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	532674887
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39595000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35994000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17351000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	627124000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	628372000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	513085000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	480164000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	511555000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	389903000	usd
CY2023	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	13655000	usd
CY2022	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	14128000	usd
CY2021	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	8645000	usd
CY2023	tlry	Office And General Expense OfficeAndGeneralExpense	27845000	usd
CY2022	tlry	Office And General Expense OfficeAndGeneralExpense	27153000	usd
CY2021	tlry	Office And General Expense OfficeAndGeneralExpense	19503000	usd
CY2023	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	57228000	usd
CY2022	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	51693000	usd
CY2021	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	37126000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39595000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35994000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17351000	usd
CY2023	us-gaap	General Insurance Expense GeneralInsuranceExpense	12033000	usd
CY2022	us-gaap	General Insurance Expense GeneralInsuranceExpense	17536000	usd
CY2021	us-gaap	General Insurance Expense GeneralInsuranceExpense	12257000	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	7166000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	13047000	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	11779000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	48000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	682000	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0	usd
CY2023	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	-0	usd
CY2022	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	4032000	usd
CY2021	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	-0	usd
CY2023	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	4530000	usd
CY2022	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	4203000	usd
CY2021	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	2711000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	3155000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	3761000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	2203000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	165159000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	162801000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	111575000	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	33025000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	11736000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	2926000	usd
CY2023	us-gaap	Interest Expense InterestExpense	46612000	usd
CY2022	us-gaap	Interest Expense InterestExpense	39680000	usd
CY2021	us-gaap	Interest Expense InterestExpense	30903000	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-13587000	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-27944000	usd
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-27977000	usd
CY2023	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-43651000	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	163670000	usd
CY2021	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-170453000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-12438000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-63913000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1234000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-25535000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-28383000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-22347000	usd
CY2023	tlry	Gain Loss On Long Term Investments GainLossOnLongTermInvestments	-2190000	usd
CY2022	tlry	Gain Loss On Long Term Investments GainLossOnLongTermInvestments	-6737000	usd
CY2021	tlry	Gain Loss On Long Term Investments GainLossOnLongTermInvestments	-2352000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-7971000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	5208000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	9080000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-66909000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	197671000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-184838000	usd
CY2023Q2	us-gaap	Contractual Obligation ContractualObligation	658655000	usd
CY2023Q2	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	228546000	usd
CY2023Q2	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	156088000	usd
CY2023Q2	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	42400000	usd
CY2023Q2	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	10522000	usd
CY2023Q2	tlry	Contractual Obligation To Be Paid After Year Four ContractualObligationToBePaidAfterYearFour	221099000	usd
CY2023Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	25000000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6641000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5404000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5404000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	1237000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6641000	usd
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4571000	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	833000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5404000	usd
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2313000	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	2258000	usd
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4571000	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	pure
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	627124000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	628372000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	513085000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	429667000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	587499000	usd
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2023	dei	Auditor Location AuditorLocation	Oakville, Canada

Files In Submission

Name	View Source	Status
0001437749-23-020727-index-headers.html	Edgar Link	pending
0001437749-23-020727-index.html	Edgar Link	pending
0001437749-23-020727.txt	Edgar Link	pending
0001437749-23-020727-xbrl.zip	Edgar Link	pending
ex_511953.htm	Edgar Link	pending
ex_511954.htm	Edgar Link	pending
ex_511955.htm	Edgar Link	pending
ex_511956.htm	Edgar Link	pending
ex_511957.htm	Edgar Link	pending
ex_511958.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
stockperformancegraphpart3.jpg	Edgar Link	pending
tlry-20230531.xsd	Edgar Link	pending
tlry20230531_10k.htm	Edgar Link	pending
tlry-20230531_def.xml	Edgar Link	unprocessable
tlry-20230531_pre.xml	Edgar Link	unprocessable
tlry20230531_10k_htm.xml	Edgar Link	completed
tlry-20230531_cal.xml	Edgar Link	unprocessable
tlry-20230531_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TLRY
Tilray Brands, Inc. Stock $tlry

2023 Q3 Form 10-K Financial Statement

#000143774923020727 Filed on July 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLRY Tilray Brands, Inc. Stock $tlry

2023 Q3 Form 10-K Financial Statement

#000143774923020727 Filed on July 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLRY
Tilray Brands, Inc. Stock $tlry